,,ii #aacth ,,congress #b;d ,session ,s4 #babf ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,march #ac1 #bjad ,mrs4 ,boxer 7for herself and ,mr4 ,kirk7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to launch a national strategy to support regenerative medicine through the establishment of a ,regenerative ,medicine ,coordinating ,council1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,regenerative ,medicine ,promotion ,act of #bjad4 #b4 ,findings ,congress finds the following3 7#a7 ,regenerative medicine has the potential to treat many chronic diseases1 promote economic growth1 and reduce health care spending in the ,united ,states4 7#b7 ,regenerative medicine products have already successfully treated numerous health conditions and have the potential to provide cures1 treatments and diagnostics for a range of diseases and disabilities including diabetes1 spinal cord injury1 heart disease1 stroke1 various forms of cancer1 and other age-related conditions that represent a huge quality of life1 social1 and economic burden on society4 7#c7 ,a ,united ,states national strategy on regenerative medicine is critical to ensure that this technology fulfills its potential to cure and treat diseases and disabilities1 reduce overall health care spending1 and promote economic growth4 7#d7 ,the ,department of ,defense has stated that regenerative medicine has the potential to treat many battlefield injuries such as burns1 that it has the potential to heal wounds without scarring1 and that it has the potential to be used for craniofacial reconstruction1 limb reconstruction1 regeneration1 and transplantation4 7#e7 ,the ,department of ,health and ,human ,services and the ,multi-,agency ,tissue ,engineering ,science ,interagency ,working ,group have endorsed a national initiative to support research and product development in regenerative medicine4 7#f7 ,the ,department of ,health and ,human ,services has said the potential benefits of regenerative medicine in improved health care and economic savings are enormous4 ,states that have invested in regenerative medicine have experienced economic growth and see future growth potential1 including an increase in biotech employment1 payroll increases1 and proportional impacts on tax receipts4 #c4 ,report on ongoing ,federal programs and activities regarding regenerative medicine ,not later than #ij days after the date of the enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall provide for the completion1 and submission to ,congress1 of a report identifying all ongoing ,federal programs and activities regarding regenerative medicine4 #d4 ,establishment of ,regenerative ,medicine ,coordinating ,council 7a7 ,establishment ,the ,secretary of ,health and ,human ,services shall establish1 in the ,office of the ,secretary1 a ,regenerative ,medicine ,coordinating ,council 7in this section referred to as the ,council74 7b7 ,composition ,the ,council shall be composed of the following3 7#a7 ,the ,secretary of ,commerce4 7#b7 ,the ,secretary of ,defense4 7#c7 ,the ,secretary of ,health and ,human ,services4 7#d7 ,the ,secretary of the ,treasury4 7#e7 ,the ,secretary of ,veterans ,affairs4 7#f7 ,the ,administrator of the ,agency for ,healthcare ,research and ,quality4 7#g7 ,the ,administrator of the ,centers for ,medicare ,medicaid ,services4 7#h7 ,the ,commissioner of ,food and ,drugs4 7#i7 ,the ,director of the ,national ,institutes of ,health4 7#aj7 ,the ,director of the ,national ,institutes of ,standards and ,technology4 7#aa7 ,such other members as may be appointed by the ,secretary of ,health and ,human ,services4 7c7 ,chair ,the ,secretary of ,health and ,human ,services shall be the ,chair of the ,council4 7d7 ,members appointed by ,secretary ,the members of the ,council appointed by the ,secretary of ,health and ,human ,services under subsection 7b77#aa7 shall include health insurers1 regenerative medicine researchers from academic institutions1 patient advocates1 persons with expertise in drug discovery1 persons with expertise in drug development1 persons with expertise in basic research1 persons with expertise in translational research1 persons with expertise in medical device development1 persons with expertise in biomaterials1 and persons with expertise in clinical research4 7e7 ,functions ,the ,council shall-- 7#a7 prepare1 and keep up-to-date1 a national strategy to support research into regenerative medicine and enable the development of drugs1 biological products1 medical devices1 and biomaterials for use in regenerative medicine2 7#b7 develop national goals for regenerative medicine research and product development2 7#c7 prepare a plan specifying priorities for research into regenerative medicine2 7#d7 identify sources of funding for research into regenerative medicine2 7#e7 identify areas where such funding is inadequate or duplicative2 7#f7 make recommendations regarding ,federal regulatory1 reimbursement1 and other policies that will support development and marketing of regenerative medicine products2 7#g7 develop consensus standards regarding scientific issues critical to regulatory approval of regenerative medicine products2 and 7#h7 determine the need for establishing centers of excellence or consortia to further advance regenerative medicine4 7f7 ,transparency2 reporting requirements 7#a7 ,transparency ,the ,council shall adopt procedures to ensure the receipt of public input1 such as holding public stakeholder meetings or creating advisory boards4 7#b7 ,annual reports ,the ,council shall submit an annual report on its activities to ,congress1 the ,director of the ,national ,institutes of ,health1 and the ,commissioner of ,food and ,drugs4 ,each such report shall-- 7,a7 provide details on progress in meeting goals identified by the ,council for regenerative medicine2 7,b7 provide recommendations regarding funding1 regulatory1 or other policies to achieve regenerative medicine goals identified by the ,council2 7,c7 identify regenerative medicine products currently on the market and those in development2 7,d7 identify regenerative medicine research and technological advances and discoveries that occurred in the previous year2 and 7,e7 assess the impact of regenerative medicine on the ,nation's economy1 including with respect to-- 7i7 the number of people employed in companies or research institutions working in regenerative medicine2 7ii7 the number of companies pursuing regenerative medicine products2 and 7iii7 increases in tax revenues4